Caesium137 implant as sole radiation therapy for operable breast cancer: A phase II trial

Radiotherapy and Oncology

Volumn 71, Issue 3, 2004, Pages 281-285

  Fentiman, Ian S ^a   Deshmane, Vinay ^a   Tong, David ^a   Winter, John ^a   Mayles, Helen ^b   Chaudary, Murid A ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

Brachytherapy; Breast cancer; Breast conservation therapy; Caesium implant

Indexed keywords

CESIUM 137; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; IMPLANT; MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RATING SCALE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CESIUM RADIOISOTOPES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 2542456417     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.02.010     Document Type: Article

References (27)

1. Baglan K.L., Martinez A.A., Frazier R.C., et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 50:2001;1003-1011
2. Blichert-Toft M., Brincker H., Andersen J.A., et al. A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Acta Oncol. 27:1988;671-677
3. Bonadonna G., Valagussa P., Rossi A., et al. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat. 5:1985;95-115
4. 192Ir wire. Br J Radiol. 58:1985;549-552
5. Chaudary M.A., Tong D., Millis R., et al. Loco-regional recurrence following mastectomy for early breast carcinoma: efficacy of radiotherapy at the time of recurrence. Eur J Surg Oncol. 23:1997;348-353
6. Clark R., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst. 88:1996;1659-1664
7. Cuzick J., Stewart H., Peto R., et al. Overview of randomised trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 71:1987;15-29
8. Dale R.G., Jones B., Price P. Comments on Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 33:1997;1707-1708
9. Fentiman I.S., Poole C., Tong D., et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer. 27:1991;447-450
10. Fentiman I.S., Poole C., Tong D., et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 32A:1996;608-611
11. Fisher B., Redmond C., Poisson R., et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 320:1989;822-828
12. Fisher B., Constantino J., Redmond C., et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor-positive tumors. N Engl J Med. 320:1989;479-484
13. Fowble B., Solin L.J., Schultz D.J., Rubenstein J., Goodman R.L. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 19:1990;833-842
14. Habibollahi F., Fentiman I.S., Chaudary M.A., et al. Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat. 13:1989;237-241
15. Holland R., Veling S.H., Mravunac M., Hendriks J.H. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast conserving surgery. Cancer. 56:1985;979-990
16. Jacobson J.A., Danforth D.N., Cowan K.H., et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 32:1995;907-911
17. Johnson J.E., Page D.L., Winfield A.C., et al. Recurrent mammary carcinoma after local excision: a segmental problem. Cancer. 75:1995;1612-1618
18. Kurtz J.M., Amalric R., Brandone H., et al. Local recurrence after breast conserving surgery and radiotherapy. Frequency, time course and prognosis. Cancer. 63:1989;1912-1917
19. Liljegren G., Holmberg L., Adami H.-O., et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomised trial. J Natl Cancer Inst. 86:1994;717-722
20. Magee B., Swindell R., Harris M., Banerjee S.S. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol. 39:1996;223-227. also p. 1996
21. Mayles W.P.M., Mayles H.M.O., Turner P.C.R. Physical aspects of interstitial therapy using flexible iridium-192 wire. Br J Radiol. 58:1985;529-536
22. Ribeiro G.G., Dunn G., Swindell R., et al. Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol. 2:1990;27-34
23. Rose M.A., Henderson I.C., Gelman R., et al. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys. 17:1989;711-717
24. Rutqvist L.E., Cedermark B., Fornander T., et al. The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer. J Clin Oncol. 7:1989;1474-1484
25. Van Dongen J.A., Bartelink H., Fentiman I.S., et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 28A:1992;801-805
26. Veronesi U., Marubini E., Del Vecchio M., et al. Local recurrence and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 87:1995;19-27
27. Veronesi U., Salvadori B., Luini A., et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1973 patients. Eur J Cancer. 31A:1995;1574-1579